Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
01 1Evonik Rexim S.A.S
02 1Flamma S.p.A.
03 1Spectrum Laboratory Products, Inc.
01 1GB001 L-Lysine salt
02 1L-LYSINE HYDRATE
03 1L-Lysine Monohydrochloride
01 1Germany
02 1Italy
03 1U.S.A
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
NDC Package Code : 51593-5011
Start Marketing Date : 1980-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54236-070
Start Marketing Date : 2020-04-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-4161
Start Marketing Date : 2020-08-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
59
PharmaCompass offers a list of Lysine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lysine manufacturer or Lysine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lysine manufacturer or Lysine supplier.
PharmaCompass also assists you with knowing the Lysine API Price utilized in the formulation of products. Lysine API Price is not always fixed or binding as the Lysine Price is obtained through a variety of data sources. The Lysine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 0013CD6B-1671-4369-B1BE-F531611E50C7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 0013CD6B-1671-4369-B1BE-F531611E50C7, including repackagers and relabelers. The FDA regulates 0013CD6B-1671-4369-B1BE-F531611E50C7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 0013CD6B-1671-4369-B1BE-F531611E50C7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 0013CD6B-1671-4369-B1BE-F531611E50C7 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 0013CD6B-1671-4369-B1BE-F531611E50C7 supplier is an individual or a company that provides 0013CD6B-1671-4369-B1BE-F531611E50C7 active pharmaceutical ingredient (API) or 0013CD6B-1671-4369-B1BE-F531611E50C7 finished formulations upon request. The 0013CD6B-1671-4369-B1BE-F531611E50C7 suppliers may include 0013CD6B-1671-4369-B1BE-F531611E50C7 API manufacturers, exporters, distributors and traders.
click here to find a list of 0013CD6B-1671-4369-B1BE-F531611E50C7 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 0013CD6B-1671-4369-B1BE-F531611E50C7 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 0013CD6B-1671-4369-B1BE-F531611E50C7 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 0013CD6B-1671-4369-B1BE-F531611E50C7 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 0013CD6B-1671-4369-B1BE-F531611E50C7 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 0013CD6B-1671-4369-B1BE-F531611E50C7 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 0013CD6B-1671-4369-B1BE-F531611E50C7 suppliers with NDC on PharmaCompass.
We have 3 companies offering 0013CD6B-1671-4369-B1BE-F531611E50C7
Get in contact with the supplier of your choice:
